Ancient Indian Herb Shows Promise for Diabetes Treatment

A team of researchers has unearthed a wealth of medicinal plants on Brahmayoni Hill in Gaya, Bihar, with Gymnema sylvestre, commonly known as Gurmar, standing out as a significant discovery. This herb, renowned for its anti-diabetic properties, has been incorporated into the anti-diabetic drug BGR-34, developed by the Council of Scientific and Industrial Research (CSIR). The researchers highlight the unique ability of Gurmar to lower blood sugar levels, attributed to the presence of gymnemic acid. This compound works by occupying receptor sites in the intestinal lining, effectively curbing cravings for sweetness and reducing sugar absorption, leading to lower blood sugar levels. Furthermore, Gurmar contains flavonoids and saponins, which play crucial roles in regulating lipid metabolism. Flavonoids possess antioxidant properties, while saponins contribute to lowering cholesterol levels. This valuable information was unveiled in a study published in the International Journal of Creative Research Thoughts (IJCRT) by Professors from Magadh University.

Gurmar is one of three medicinal plants found on Brahmayoni Hill, a site rich in natural remedies, which traditional healers have relied upon for centuries. Gurmar’s anti-diabetic properties have garnered particular attention. Notably, the researchers point out that Gurmar is a key ingredient in BGR-34, an anti-diabetic Ayurvedic formulation developed by CSIR and marketed by Aimil Pharma. In 2022, a study conducted by the All India Institute of Medical Sciences (AIIMS), Delhi, validated the efficacy of BGR-34 in reducing obesity and blood sugar levels, while simultaneously enhancing the body’s metabolic system. Dr. Sanchit Sharma, Executive Director of Aimil Pharma, emphasizes that BGR-34’s effectiveness stems from a blend of phyto-ingredients, including Gurmar, Daruharidra, Giloy, Vijaysar, Manjishtha, and Fenugreek, all working together to manage diabetes. Dr. Sharma further highlights the increasing popularity of herbal-based Ayurvedic medicines, fueled by the growing prevalence of non-communicable diseases linked to lifestyle changes and a heightened focus on preventive health.

The researchers, in their study titled ‘Ethnobotanical research on certain therapeutic plants found on Gaya’s Brahmayoni Hill,’ draw a parallel between BGR-34 and Metformin, the first diabetes drug, which was also derived from a medicinal plant, Galega. Based on this, they strongly advocate for further in-depth research on Gymnema (Gurmar) to unveil its full therapeutic potential and provide the next generation with an effective treatment option. They also emphasize the importance of involving local populations in the cultivation of the most commonly used medicinal herbs found on Brahmayoni Hill to prevent their extinction. This collaborative approach would ensure the sustainability and availability of these valuable medicinal resources for generations to come.

Related posts:

India Raises Prices of Essential Medicines for Diabetes, Heart Disease, and More Affidea Partners with Reset Health to Launch Roczen: A Digital Platform for Personalized Obesity and Diabetes Management Affidea Partners with Reset Health to Launch Roczen: A Digital Platform for Personalized Obesity and Diabetes Management